mitoxantrone has been researched along with Dyspnea in 2 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Dyspnea: Difficult or labored breathing.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franke, M | 1 |
| Theurich, S | 1 |
| Beyer, F | 1 |
| Persigehl, T | 1 |
| Brito-Babapulle, F | 1 |
| Barbatis, C | 1 |
| Whitmore, DN | 1 |
2 other studies available for mitoxantrone and Dyspnea
| Article | Year |
|---|---|
[Pulmonary differentiation -/ATRA syndrome within the scope of therapy of acute promyelocytic leukemia (APL)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Diagnosis, Differential; D | 2014 |
Laryngeal infiltration in chronic myelomonocytic leukaemia.
Topics: Aged; Airway Obstruction; Dyspnea; Female; Granulocytes; Humans; Larynx; Leukemia, Myelomonocytic, C | 1989 |